Evolutionary Fingerprints of EMT in Pancreatic Cancers
Luigi Perelli,Li Zhang,Sarah Mangiameli,Andrew J C Russell,Francesca Giannese,Fuduan Peng,Federica Carbone,Courtney Le,Hania Khan,Francesca Citron,Melinda Soeung,Truong Nguyen Anh Lam,Sebastian Lundgren,Cihui Zhu,Desiree Catania,Ningping Feng,Enrico Gurreri,Alessandro Sgambato,Giampaolo Tortora,Giulio F Draetta,Giovanni Tonon,Andrew Futreal,Virginia Giuliani,Alessandro Carugo,Andrea Viale,Timothy P Heffernan,Linghua Wang,Davide Cittaro,Fei Chen,Giannicola Genovese
DOI: https://doi.org/10.1101/2023.09.18.558231
2023-01-01
Abstract:Mesenchymal plasticity has been extensively described in advanced and metastatic epithelial cancers; however, its functional role in malignant progression, metastatic dissemination and therapy response is controversial. More importantly, the role of epithelial mesenchymal transition (EMT) and cell plasticity in tumor heterogeneity, clonal selection and clonal evolution is poorly understood. Functionally, our work clarifies the contribution of EMT to malignant progression and metastasis in pancreatic cancer. We leveraged ad hoc somatic mosaic genome engineering, lineage tracing and ablation technologies and dynamic genetic reporters to trace and ablate tumor-specific lineages along the phenotypic spectrum of epithelial to mesenchymal plasticity. The experimental evidences clarify the essential contribution of mesenchymal lineages to pancreatic cancer evolution and metastatic dissemination. Spatial genomic analysis combined with single cell transcriptomic and epigenomic profiling of epithelial and mesenchymal lineages reveals that EMT promotes with the emergence of chromosomal instability (CIN). Specifically tumor lineages with mesenchymal features display highly conserved patterns of genomic evolution including complex structural genomic rearrangements and chromotriptic events. Genetic ablation of mesenchymal lineages robustly abolished these mutational processes and evolutionary patterns, as confirmed by cross species analysis of pancreatic and other human epithelial cancers. Mechanistically, we discovered that malignant cells with mesenchymal features display increased chromatin accessibility, particularly in the pericentromeric and centromeric regions, which in turn results in delayed mitosis and catastrophic cell division. Therefore, EMT favors the emergence of high-fitness tumor cells, strongly supporting the concept of a cell-state, lineage-restricted patterns of evolution, where cancer cell sub-clonal speciation is propagated to progenies only through restricted functional compartments. Restraining those evolutionary routes through genetic ablation of clones capable of mesenchymal plasticity and extinction of the derived lineages completely abrogates the malignant potential of one of the most aggressive form of human cancer.